290 related articles for article (PubMed ID: 29923223)
1. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma.
Wu Y; Wei J; Ming Y; Chen Z; Yu J; Mao R; Chen H; Zhou G; Fan Y
J Cell Biochem; 2018 Sep; 119(9):7696-7706. PubMed ID: 29923223
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC.
Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y
Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694
[TBL] [Abstract][Full Text] [Related]
4. Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma.
Yu X; Lin Y; Sui W; Zou Y; Lv Z
Cancer Med; 2017 Mar; 6(3):673-680. PubMed ID: 28220683
[TBL] [Abstract][Full Text] [Related]
5. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma.
Fu XL; Liu DJ; Yan TT; Yang JY; Yang MW; Li J; Huo YM; Liu W; Zhang JF; Hong J; Hua R; Chen HY; Sun YW
Sci Rep; 2016 Sep; 6():33535. PubMed ID: 27628540
[TBL] [Abstract][Full Text] [Related]
6. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
7. Microarray expression profile analysis of long non-coding RNAs in pancreatic ductal adenocarcinoma.
Zhou Y; Gong B; Jiang ZL; Zhong S; Liu XC; Dong K; Wu HS; Yang HJ; Zhu SK
Int J Oncol; 2016 Feb; 48(2):670-80. PubMed ID: 26676849
[TBL] [Abstract][Full Text] [Related]
8. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
9. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.
Tahira AC; Kubrusly MS; Faria MF; Dazzani B; Fonseca RS; Maracaja-Coutinho V; Verjovski-Almeida S; Machado MC; Reis EM
Mol Cancer; 2011 Nov; 10():141. PubMed ID: 22078386
[TBL] [Abstract][Full Text] [Related]
11. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma.
Ding YC; Yu W; Ma C; Wang Q; Huang CS; Huang T
Int J Clin Exp Pathol; 2014; 7(11):8065-70. PubMed ID: 25550852
[TBL] [Abstract][Full Text] [Related]
12. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma.
Huang S; Li Y; Hu J; Li L; Liu Z; Guo H; Jiang B; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2021 May; 25(9):4275-4286. PubMed ID: 33834618
[TBL] [Abstract][Full Text] [Related]
13. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential.
Pandya G; Kirtonia A; Sethi G; Pandey AK; Garg M
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188423. PubMed ID: 32871244
[TBL] [Abstract][Full Text] [Related]
14. Multi-level integrative analysis of the roles of lncRNAs and differential mRNAs in the progression of chronic pancreatitis to pancreatic ductal adenocarcinoma.
Zhao Z; Luo Q; Liu Y; Jiang K; Zhou L; Dai R; Wang H
BMC Genomics; 2023 Mar; 24(1):101. PubMed ID: 36879212
[TBL] [Abstract][Full Text] [Related]
15. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.
Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R
J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763
[TBL] [Abstract][Full Text] [Related]
16. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
17. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer.
Giulietti M; Righetti A; Principato G; Piva F
Carcinogenesis; 2018 Jul; 39(8):1016-1025. PubMed ID: 29796634
[TBL] [Abstract][Full Text] [Related]
18. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma.
Hu Y; Chen Y
Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315
[TBL] [Abstract][Full Text] [Related]
19. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways.
Liang X; Qi M; Wu R; Liu A; Chen D; Tang L; Chen J; Hu X; Li W; Zhan L; Shao C
Int J Oncol; 2018 Dec; 53(6):2671-2682. PubMed ID: 30272271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
